SOX2 and ovarian carcinoma: Using a highly aggressive and metastatic ovarian cancer cell line (HEY) which sustains high endogenous expression of Oct4A, we show that suppression of Oct4A resulted in the loss of CSC-associated expression of Lin28, Sox-2, EpCAM and CD44.